Aura Biosciences, Inc. (AURA) has 7 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 1, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 1, 2026 | Person Julie Chief People Officer | $0 | 320,000 | +103% | No | |
|
|
||||||
| Sept. 1, 2026 | Kratz Erica Chief Reg. & Quality Officer | $0 | 300,000 | +103% | No | |
|
|
||||||
| Sept. 1, 2026 | Hopkins Janet Jill Chief Medical Officer | $0 | 175,000 | +103% | No | |
|
|
||||||
| Sept. 1, 2026 | Elazzouzi Amy SVP, Finance & PAO | $0 | 70,000 | +103% | No | |
|
|
||||||
| Sept. 1, 2026 | Abu-Absi Susan Chief Operating Officer | $0 | 400,000 | +103% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free